Two Sigma Advisers
BEAM icon

Two Sigma Advisers’s Beam Therapeutics BEAM Stock Holding History

Two Sigma Advisers’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-527,802
Closed -$14.6M – 261
2025
Q4 		$14.6M Buy
527,802
+194,802
+58% +$4.97M 0.03% 428
2025
Q3 		$8.08M Sell
333,000
-220,100
-40% -$4.38M 0.02% 567
2025
Q2 		$9.41M Buy
553,100
+448,200
+427% +$7.81M 0.02% 528
2025
Q1 		$2.05M Buy
104,900
+85,900
+452% +$2.25M ﹤0.01% 1149
2024
Q4 		$471K Buy
19,000
+8,300
+78% +$212K ﹤0.01% 1799
2024
Q3 		$262K Sell
10,700
-32,100
-75% -$829K ﹤0.01% 1968
2024
Q2 		$1M Sell
42,800
-105,400
-71% -$2.59M ﹤0.01% 1552
2024
Q1 		$4.9M Buy
+148,200
New +$4.62M 0.01% 787
2023
Q3 		– Sell
-8,500
Closed -$271K – 2394
2023
Q2 		$271K Sell
8,500
-16,400
-66% -$532K ﹤0.01% 2011
2023
Q1 		$762K Sell
24,900
-21,500
-46% -$849K ﹤0.01% 1765
2022
Q4 		$1.81M Sell
46,400
-54,600
-54% -$2.45M 0.01% 1294
2022
Q3 		$4.81M Buy
101,000
+50,600
+100% +$2.89M 0.01% 752
2022
Q2 		$1.95M Buy
+50,400
New +$2M 0.01% 1232
2022
Q1 		– Sell
-13,700
Closed -$1.09M – 2737
2021
Q4 		$1.09M Sell
13,700
-51,700
-79% -$4.43M ﹤0.01% 1524
2021
Q3 		$5.69M Buy
65,400
+13,100
+25% +$1.32M 0.01% 726
2021
Q2 		$6.73M Buy
+52,300
New +$4.17M 0.02% 725

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Two Sigma Advisers's BEAM Position: Q1 2026 in Review

Two Sigma Advisers sold out of Beam Therapeutics (BEAM) in Q1 2026, closing a stake of 527,802 shares — an estimated $14.6M sold.

Two Sigma Advisers first reported a position in BEAM in Q2 2021 and held it in 16 quarters. The position peaked at $14.6M in Q4 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Two Sigma Advisers reported no remaining Beam Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 527,802 Beam Therapeutics shares in Q1 2026, an estimated $14.6M.
  • Two Sigma Advisers first reported a position in Beam Therapeutics in Q2 2021 and held it in 16 quarters.
  • Two Sigma Advisers's Beam Therapeutics position peaked at $14.6M in Q4 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.